Establishment of a PCR analysis method for canine BRCA2

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Yoshikawa, Yasunaga ^a   Morimatsu, Masami ^b   Ochiai, Kazuhiko ^c   Okuda, Kento ^a   Taoda, Takahiro ^a   Chikazawa, Seishiro ^a   Shimamura, Asako ^c   Omi, Toshinori ^c   Bonkobara, Makoto ^c   Orino, Koichi ^a   Watanabe, Kiyotaka ^a  

^a KITASATO UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

BRCA2 PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DOG DISEASE; EXPERIMENTAL NEOPLASM; FEMALE; GENE FREQUENCY; GENETICS; GENOTYPE; HUMAN; INDEL MUTATION; MALE; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; OVARY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TESTIS;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BRCA2 PROTEIN; DNA MUTATIONAL ANALYSIS; DOG DISEASES; DOGS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INDEL MUTATION; MALE; MAMMARY NEOPLASMS, ANIMAL; MOLECULAR SEQUENCE DATA; MUTATION; OVARY; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TESTIS;

EID: 84859206624     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-173     Document Type: Article

References (23)

1. Breast cancer statistics, 2011. DeSantis C, Siegel R, Bandi P, Jemal A, CA Cancer J Clin 2011 61 6 409 418 21969133
2. Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Egenvall A, Bonnett BN, Ohagen P, Olson P, Hedhammar A, von Euler H, Prev Vet Med 2005 69 1-2 109 127 10.1016/j.prevetmed.2005.01.014 15899300 (Pubitemid 40717527)
3. Population-based incidence of mammary tumours in some dog breeds. Moe L, J Reprod Fertil Suppl 2001 57 439 443 11787188
4. Mammary tumors in a colony of beagle dogs. Moulton JE, Rosenblatt LS, Goldman M, Vet Pathol 1986 23 6 741 749 3811139
5. Canine mammary epithelial neoplasms: biologic implications of morphologic characteristics assessed in 232 dogs. Gilbertson SR, Kurzman ID, Zachrau RE, Hurvitz AI, Black MM, Vet Pathol 1983 20 2 127 142 6836870 (Pubitemid 13087502)
6. Canine mammary tumors. Moulton JE, Taylor DO, Dorn CR, Andersen AC, Pathol Vet 1970 7 4 289 320 10.1177/030098587000700401 4328309
7. Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family. Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER, BMC Cancer 2008 8 155 10.1186/1471-2407-8-155 18513387 (Pubitemid 352024891)
8. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. King M-C, Marks JH, Mandell JB, Group NYBCS, Science 2003 302 5645 643 646 10.1126/science.1088759 14576434 (Pubitemid 37310920)
9. Mammary tumor development in dogs is associated with BRCA1 and BRCA2. Rivera P, Melin M, Biagi T, Fall T, Haggstrom J, Lindblad-Toh K, von Euler H, Cancer Res 2009 69 22 8770 8774 10.1158/0008-5472.CAN-09-1725 19887619
10. Molecular biological aspects on canine and human mammary tumors. Rivera P, von Euler H, Vet Pathol 2011 48 1 132 146 10.1177/0300985810387939 21147766
11. Novel variations and loss of heterozygosity of BRCA2 identified in a dog with mammary tumors. Yoshikawa Y, Morimatsu M, Ochiai K, Nagano M, Tomioka Y, Sasaki N, Hashizume K, Iwanaga T, Am J Vet Res 2008 69 10 1323 1328 10.2460/ajvr.69.10.1323 18828690
12. Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue. Hsu W-L, Huang Y-H, Chang T-J, Wong M-L, Chang S-C, Vet J 2010 184 3 351 356 10.1016/j.tvjl.2009.03.022 19944633
13. Insertion/deletion polymorphism in the BRCA2 nuclear localization signal. Yoshikawa Y, Morimatsu M, Ochiai K, Nagano M, Yamane Y, Tomizawa N, Sasaki N, Hashizume K, Biomed Res 2005 26 3 109 116 10.2220/biomedres.26.109 16011303 (Pubitemid 41519983)
14. Cloning and sequencing full length of canine Brca2 and Rad51 cDNA. Ochiai K, Morimatsu M, Tomizawa N, Syuto B, J Vet Med Sci 2001 63 10 1103 1108 10.1292/jvms.63.1103 11714026 (Pubitemid 33645190)
15. Identification of genetic variation in 11 candidate genes of canine mammary tumour. Borge KS, Børresen-Dale AL, Lingaas F, Vet Comp Oncol 2011 9 4 241 250 10.1111/j.1476-5829.2010.00250.x 22077404
16. Expression patterns of the BRCA1 splicing variants in canine normal tissues and mammary gland tumors. Sugiura T, Matsuyama S, Akiyosi H, Takenaka S, Yamate J, Kuwamura M, Aoki M, Shimada T, Ohashi F, Kubo K, J Vet Med Sci 2007 69 6 587 592 10.1292/jvms.69.587 17611353 (Pubitemid 47036506)
17. Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicity. Walker LC, Whiley PJ, Couch FJ, Farrugia DJ, Healey S, Eccles DM, Lin F, Butler SA, Goff SA, Thompson BA, et al. Hum Mutat 2010 31 6 1484 1505 10.1002/humu.21267 20513136
18. Analysis of genetic variations in the exon 27 region of the canine BRCA2 locus. Yoshikawa Y, Morimatsu M, Ochiai K, Nagano M, Yamane Y, Tomizawa N, Sasaki N, Hashizume K, J Vet Med Sci 2005 67 10 1013 1017 10.1292/jvms.67.1013 16276057 (Pubitemid 41634658)
19. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hussain S, Witt E, Huber PAJ, Medhurst AL, Ashworth A, Mathew CG, Hum Mol Genet 2003 12 19 2503 2510 10.1093/hmg/ddg266 12915460 (Pubitemid 37220414)
20. Interactions between canine RAD51 and full length or truncated BRCA2 BRC repeats. Ochiai K, Yoshikawa Y, Oonuma T, Tomioka Y, Hashizume K, Morimatsu M, Vet J 2011 190 2 293 295 10.1016/j.tvjl.2010.11.001 21123097
21. The BRCA2 is a histone acetyltransferase. Siddique H, Zou JP, Rao VN, Reddy ES, Oncogene 1998 16 17 2283 2285 10.1038/sj.onc.1202003 9619837 (Pubitemid 28220658)
22. Biallelic inactivation of BRCA2 in Fanconi anemia. Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, Persky N, Grompe M, Joenje H, Pals G, et al. Science 2002 297 5581 606 609 10.1126/science.1073834 12065746 (Pubitemid 34815345)
23. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C, Sands A, Eichele G, Hasty P, Bradley A, Nature 1997 386 6627 804 810 10.1038/386804a0 9126738 (Pubitemid 27181248)